Elevance Health, Inc.

For the period ended Jun 30, 2026. Filed Jul 15, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Jul 15, 2026

ELV$418.25-1.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	ELEVANCE HEALTH, INC.Registrant
July 15, 2026	By:	/S/ MARK B. KAYE
		Mark B. KayeExecutive Vice President and Chief Financial Officer(Duly Authorized Officer and Principal Financial Officer)
July 15, 2026	By:	/S/ RONALD W. PENCZEK
		Ronald W. PenczekChief Accounting Officer and Controller(Principal Accounting Officer)

-56-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.